logo

For the Inventor, By the Inventor

Ghaziabad, India

Anand C Burman

This inventor holds 24 USPTO granted patents and 2 EPO patents, primarily in Cancer Therapeutics. Top assignees: Dabur Research Foundation, Dabur Pharma Limited, Fresenius Kabi Oncology Limited. Active years: 2001-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anand C Burman. Retrieved from https://idiyas.com/inventor/anand-c-burman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24

% Patents Active = 37.5

 

Average Co-Inventor Count = 6.4

ph-index = 6

Forward Citations = 154(Granted Patents)


Location History:

  • London, GB (2003)
  • Regents Park, GB (2003)
  • Sahibabad, IN (2007 - 2010)
  • Sahibabad Ghaziabad, IN (2010)
  • Uttar Pradesh, IN (2002 - 2011)
  • Ghaziabad, IN (2001 - 2015)

Company Filing History:

goldMedal16 out of 29 
 
Dabur Research Foundation
 patents
silverMedal3 out of 5 
 
Dabur Pharma Limited
 patents
bronzeMedal3 out of 33 
 
Fresenius Kabi Oncology Limited
 patents
4. 2 out of 834,570 
Other
 patents

Years Active: 2001-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Biocompatible Polymer
Nanoparticle Formulations
Cancer Treatment
Peptide Analogs
Paclitaxel Derivatives
Vasoactive Intestinal Peptide
Anti-Cancer Activity
Drug Formulations
Synthetic Peptides
Pharmaceutical Compositions
Stabilized Formulations
Radiolabeled Compounds
24 patents (USPTO):Explore Patents
1. 8927023 - Biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions (2015-01-06),
2. 8338562 - Biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions (2012-12-25),
3. 8022055 - Betulinic acid derivatives (2011-09-20),
4. 7781398 - Drug comprising synthetic peptide analogs for the treatment of cancer (2010-08-24),
5. 7699987 - Stabilized formulation (2010-04-20),
6. 7674824 - Stable oxaliplatin formulation (2010-03-09),
7. 7179937 - Cyclopentenone derivatives for cancer therapy (2007-02-20),
8. 7173006 - Drug comprising synthetic peptide analogs for the treatment of cancer (2007-02-06),
9. 7094755 - Vasoactive intestinal peptide analogs (2006-08-22),
10. 7060678 - Peptides comprising furanoid sugar amino acids for the treatment of cancer (2006-06-13),
11. 6989371 - Bombesin analogs for treatment of cancer (2006-01-24),
12. 6949513 - Polypeptides of covalently linked synthetic bioactive peptide analog(s) for treatment of cancer (2005-09-27),
13. 6828304 - Peptides for treatment of cancer (2004-12-07),
14. 6656970 - Method and compositions for solubilization of pentacyclic triterpenes (2003-12-02),
15. 6632832 - Anti-cancer activity of carvedilol and its isomers (2003-10-14),

Title: Innovations by Anand C Burman: Pioneering Biocompatible Polymer Technology

Introduction

Anand C Burman, based in Ghaziabad, India, is a notable inventor with a significant contribution to the field of pharmaceuticals. With an impressive portfolio of 24 patents, he has dedicated his career to developing innovative solutions that advance medical technology and enhance patient care.

Latest Patents

One of Anand C Burman's latest patents involves a biocompatible, non-biodegradable, and non-toxic polymer designed for nanoparticle pharmaceutical compositions. This invention includes a unique formula comprising three monomeric units: 1-Vinylpyrrolidone (VP), N-Isopropylacrylamide (NIPAM), and an ester of Maleic anhydride and Polyethylene glycol (MPEG). The polymer is cross-linked with a bi-functional vinyl derivative, ensuring high purity and a significant reduction of toxic monomeric contaminants. This innovative polymer facilitates the formulation of nanoparticulate pharmaceutical compositions for poorly water-soluble drugs, offering safe and less-toxic options for bedside administration to patients. Furthermore, the patent details a highly selective method for preparing these nanoparticulate compositions, solidifying Burman's role as a leading innovator in pharmaceutical applications.

Career Highlights

Anand has made significant strides in his career, working with esteemed organizations such as Dabur Research Foundation and Fresenius Kabi Oncology Limited. His expertise in polymer chemistry and pharmaceutical technology has been instrumental in the advancement of various innovative projects throughout his tenure at these institutions.

Collaborations

Throughout his career, Anand has collaborated with esteemed colleagues, including Rama Mukherjee and Manu Jaggi. These partnerships have fostered an environment of innovation and have contributed to the successful development of impactful patents in the biomedical field.

Conclusion

Anand C Burman's contributions to pharmaceutical science through his inventions and patents underscore his status as a key figure in the industry. His work in biocompatible polymers not only advances therapeutic applications but also enriches the potential for safer and more effective medical treatments. His innovative spirit and collaboration with talented professionals highlight the importance of teamwork in driving forward the frontiers of medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…